Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Time-kill kinetics of Streptococcus pneumoniae with reduced susceptibility to telithromycin.

Chemotherapy - 1 Jan 2007

Al-Lahham Adnan, Reinert Ralf René

Abstract excerpt

BACKGROUND: Telithromycin is a new ketolide increasingly used in Europe and the United States. Only very few telithromycin-resistant isolates have been described to date. METHODS: The anti-pneumococcal activity of telithromycin was determined against four clinical isolates of Streptococcus pneumoniae with reduced susceptibility to telithromycin by time-kill methodology. RESULTS: All four telithromycin...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Bacterial Agents
Share to Drug Resistance, Bacterial
Share to Genotype

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Kinetics

Share to Microbial Sensitivity Tests

Share to Phenotype

Share to Streptococcus pneumoniae

Source

Identifiers

PMID: 17347565
DOI: 10.1159/000100517

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Time-kill kinetics of Streptococcus pneumoniae with reduced susceptibility to telithromycin.PMID 17347565Read ↗

Evaluation of telithromycin against Streptococcus pneumoniae with ribosomal mutations utilizing in vitro time-kill methodology.Semantic proximity Read ↗

Time-kill study of the activity of telithromycin against macrolide-resistant Streptococcus pneumoniae Isolates with 23S rRNA mutations and changes in ribosomal proteins L4 and L22.Semantic proximity Read ↗

Activity of telithromycin against multi-drug resistant Streptococcus pneumoniae and molecular characterization of macrolide and tetracycline resistance determinants.Semantic proximity Read ↗

Mechanisms of resistance to telithromycin in Streptococcus pneumoniae.Semantic proximity Read ↗

Mutational analysis of reduced telithromycin susceptibility of Streptococcus pneumoniae isolated clinically in Japan.Semantic proximity Read ↗

Telithromycin-nonsusceptible clinical isolates of Streptococcus pneumoniae from Europe.Semantic proximity Read ↗

In vitro activities of the novel ketolide telithromycin (HMR 3647) against erythromycin-resistant Streptococcus species.Semantic proximity Read ↗

High prevalence of the ermB gene among erythromycin-resistant streptococcus pneumoniae isolates in Germany during the winter of 2000-2001 and in vitro activity of telithromycin.Semantic proximity Read ↗

Activities of telithromycin against 13,874 Streptococcus pneumoniae isolates collected between 1999 and 2003.Semantic proximity Read ↗

High-level telithromycin resistance in laboratory-generated mutants of Streptococcus pneumoniae.Semantic proximity Read ↗

Assessment of the efficacy of telithromycin simulating human exposures against S. pneumoniae with ribosomal mutations in a murine pneumonia model.Semantic proximity Read ↗

Genotypic characterization of macrolide-resistant strains of Streptococcus pneumoniae isolated in Quebec, Canada, and in vitro activity of ABT-773 and telithromycin.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.